Outcome of Board Meeting for Q1 of 2025-2026, along with other business matters, w.r.t. re-appointment of MD.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 0.5 pts less than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dalal Street Investments' board, which met on July 29, 2025, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). The company reported total revenue of Rs. 11.26 lakhs (down from Rs. 37.19 lakhs in Q1 FY25) and a net loss of Rs. 24.09 lakhs versus a profit of Rs. 6.90 lakhs in the same quarter last year; basic EPS was Rs. (7.65). Revenue from operations remained nil for the quarter. The board also re-appointed Mrs. Geeta Manekshana (DIN: 03282077) as Managing Director & CEO for a fresh 3-year term from May 25, 2025 to May 24, 2028, subject to shareholder approval. She is the wife of Mr. Murzash Manekshana, Director and Promoter of the company.
Shareholders should note the weak Q1 results with a swing from profit to loss and zero operating revenue, while the continuation of a promoter-family member as MD & CEO means leadership continuity but reinforces concentrated family control at the top.